Renovaro Biosciences Inc (RENB) — Cash Flow Quality Index

Latest as of March 2025: 0.00x

Renovaro Biosciences Inc (RENB) has a Cash Flow Quality Index of 0.00x as of March 2025. Operating cash flow of $-1.49 Million is below net income of $39.68 Trillion, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Renovaro Biosciences Inc to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

0.00x

Operating CF / Net Income

Operating Cash Flow

$-1.49 Million

USD

Net Income

$39.68 Trillion

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Renovaro Biosciences Inc (None–None)

Year-by-year earnings quality comparison for Renovaro Biosciences Inc. For live market cap and the full company financial profile, see Renovaro Biosciences Inc market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.